147 related articles for article (PubMed ID: 30538744)
1. Current Management of Polycystic Ovary Syndrome: From Bench to Bedside.
Laganà AS; Vitale SG; Noventa M; Vitagliano A
Int J Endocrinol; 2018; 2018():7234543. PubMed ID: 30538744
[No Abstract] [Full Text] [Related]
2. The role of metformin in the management of polycystic ovary syndrome.
Tsilchorozidou T; Prelevic GM
Curr Opin Obstet Gynecol; 2003 Dec; 15(6):483-8. PubMed ID: 14624214
[TBL] [Abstract][Full Text] [Related]
3. Current Insights Into Inositol Isoforms, Mediterranean and Ketogenic Diets for Polycystic Ovary Syndrome: From Bench to Bedside.
Muscogiuri G; Palomba S; Laganà AS; Orio F
Curr Pharm Des; 2016; 22(36):5554-5557. PubMed ID: 27510483
[TBL] [Abstract][Full Text] [Related]
4. Management of polycystic ovary syndrome.
Yasmin E; Balen AH
Womens Health (Lond); 2007 May; 3(3):355-67. PubMed ID: 19803994
[TBL] [Abstract][Full Text] [Related]
5. Polycystic ovary syndrome: a common reproductive syndrome with long-term metabolic consequences.
Yau TT; Ng NY; Cheung LP; Ma RC
Hong Kong Med J; 2017 Dec; 23(6):622-34. PubMed ID: 29170361
[TBL] [Abstract][Full Text] [Related]
6. From bench to bedside: Current developments and future possibilities of artificial human ovary to restore fertility.
Salama M; Woodruff TK
Acta Obstet Gynecol Scand; 2019 May; 98(5):659-664. PubMed ID: 30714119
[TBL] [Abstract][Full Text] [Related]
7. The obstetrician-gynecologist's role in the practical management of polycystic ovary syndrome.
Berga SL
Am J Obstet Gynecol; 1998 Dec; 179(6 Pt 2):S109-S113. PubMed ID: 9855617
[TBL] [Abstract][Full Text] [Related]
8. Polycystic ovary syndrome: current and future treatment paradigms.
Legro RS
Am J Obstet Gynecol; 1998 Dec; 179(6 Pt 2):S101-S108. PubMed ID: 9855616
[TBL] [Abstract][Full Text] [Related]
9. Current perspectives of insulin resistance and polycystic ovary syndrome.
Pauli JM; Raja-Khan N; Wu X; Legro RS
Diabet Med; 2011 Dec; 28(12):1445-54. PubMed ID: 21950959
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of polycystic ovary syndrome throughout life.
Louwers YV; Laven JSE
Ther Adv Reprod Health; 2020; 14():2633494120911038. PubMed ID: 32518918
[TBL] [Abstract][Full Text] [Related]
11. Ghrelin is independently associated with anti-mullerian hormone levels in obese but not non-obese women with polycystic ovary syndrome.
Garin MC; Butts SF; Sarwer DB; Allison KC; Senapati S; Dokras A
Endocrine; 2017 Mar; 55(3):907-913. PubMed ID: 28004236
[TBL] [Abstract][Full Text] [Related]
12. Relationship of Biological Markers of Body Fat Distribution and Corticosteroidogenic Enzyme Activities in Women with Polycystic Ovary Syndrome.
de Medeiros SF; de Medeiros MAS; Barbosa BB; Yamamoto MMW
Horm Metab Res; 2019 Oct; 51(10):639-648. PubMed ID: 31578050
[TBL] [Abstract][Full Text] [Related]
13. Carotid atherosclerosis in women with polycystic ovary syndrome: initial results from a case-control study.
Guzick DS; Talbott EO; Sutton-Tyrrell K; Herzog HC; Kuller LH; Wolfson SK
Am J Obstet Gynecol; 1996 Apr; 174(4):1224-9; discussion 1229-32. PubMed ID: 8623850
[TBL] [Abstract][Full Text] [Related]
14. Tackling polycystic ovary syndrome.
Drug Ther Bull; 2001 Jan; 39(1):1-5. PubMed ID: 11221187
[TBL] [Abstract][Full Text] [Related]
15. Effects of orlistat on serum androgen levels among iranian obese women with polycystic ovarian syndrome.
Salehpour S; Hosseini S; Nazari L; Saharkhiz N; Zademodarres S
JBRA Assist Reprod; 2018 Sep; 22(3):180-184. PubMed ID: 29757582
[TBL] [Abstract][Full Text] [Related]
16. A snapshot of the lives of women with polycystic ovary syndrome: A photovoice investigation.
Williams S; Sheffield D; Knibb RC
J Health Psychol; 2016 Jun; 21(6):1170-82. PubMed ID: 25205774
[TBL] [Abstract][Full Text] [Related]
17. Differential activity of the corticosteroidogenic enzymes in normal cycling women and women with polycystic ovary syndrome.
Yamamoto MMW; de Medeiros SF
Rev Endocr Metab Disord; 2019 Mar; 20(1):3-13. PubMed ID: 30798426
[TBL] [Abstract][Full Text] [Related]
18. Body morphology and its impact on adolescent and pediatric gynecology, with a special emphasis on polycystic ovary syndrome.
Biro FM
Curr Opin Obstet Gynecol; 2003 Oct; 15(5):347-51. PubMed ID: 14501236
[TBL] [Abstract][Full Text] [Related]
19. Coronary artery disease risk in young women with polycystic ovary syndrome.
Ding DC; Tsai IJ; Wang JH; Lin SZ; Sung FC
Oncotarget; 2018 Feb; 9(9):8756-8764. PubMed ID: 29492235
[TBL] [Abstract][Full Text] [Related]
20. Weight Loss and Medication in Polycystic Ovary Syndrome Therapy.
Tolstoi LG; Josimovich JB
Nutr Today; 2002; 37(2):57-62. PubMed ID: 11984434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
